Continuous Flow Synthesis of Thieno[2,3-disoquinolin-5(4H)-one Scaffold: A Valuable Source of PARP-1 Inhibitors

被引:38
作者
Filipponi, Paolo [1 ]
Ostacolo, Carmine [2 ]
Novellino, Ettore [2 ]
Pellicciari, Roberto [1 ,3 ]
Gioiello, Antimo [1 ]
机构
[1] Univ Perugia, Dipartimento Sci Farmaceut, I-06123 Perugia, Italy
[2] Univ Naples Federico II, Dipartimento Farm, I-80131 Naples, Italy
[3] TES Pharma Srl, I-06073 Perugia, Italy
关键词
ALLERGIC AIRWAY INFLAMMATION; CROSS-COUPLING REACTIONS; NEURONAL DEATH; CANCER-CELLS; SUZUKI; DESIGN; BATCH; CATALYST; SALTS;
D O I
10.1021/op500074h
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
An efficient multistep method for the continuous flow synthesis of thieno[2,3-c]isoquinolin-5(4H)-one-A (TIQ-A), an important pharmacological tool and building block for PARP-1 inhibitors, has been developed. The synthesis involves a Suzuki coupling reaction to generate 3-phenylthiophene-2-carboxylic acid which is transformed into the corresponding acyl azide and readily cyclized by a thermal Curtius rearrangement. A statistical design of experiments (DoE) was employed as a valuable support for decision-making of further experiments enabling the development of a robust and reliable protocol for large-scale preparation. As a result, the reactions are facile, safe, and easy to scale-up. The large-scale applicability of this improved flow method was tested by conducting the reactions on multigram scale to produce the desired product in high yield and quality for biopharmacological appraisals.
引用
收藏
页码:1345 / 1353
页数:9
相关论文
共 39 条
[1]   NAD+ Depletion Is Necessary and Sufficient for Poly(ADP-Ribose) Polymerase-1-Mediated Neuronal Death [J].
Alano, Conrad C. ;
Garnier, Philippe ;
Ying, Weihai ;
Higashi, Youichirou ;
Kauppinen, Tiina M. ;
Swanson, Raymond A. .
JOURNAL OF NEUROSCIENCE, 2010, 30 (08) :2967-2978
[2]   Microwave-assisted Suzuki coupling reactions with an encapsulated palladium catalyst for batch and continuous-flow transformations [J].
Baxendale, Ian R. ;
Griffiths-Jones, Charlotte M. ;
Ley, Steven V. ;
Tranmer, Geoffrey K. .
CHEMISTRY-A EUROPEAN JOURNAL, 2006, 12 (16) :4407-4416
[3]   Palladium catalysts for the Suzuki cross-coupling reaction: An overview of recent advances [J].
Bellina, F ;
Carpita, A ;
Rossi, R .
SYNTHESIS-STUTTGART, 2004, (15) :2419-2440
[4]   A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells [J].
Castiel, Asher ;
Visochek, Leonid ;
Mittelman, Leonid ;
Dantzer, Francoise ;
Izraeli, Shai ;
Cohen-Armon, Malka .
BMC CANCER, 2011, 11
[5]   Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis [J].
Costantino, G ;
Macchiarulo, A ;
Camaioni, E ;
Pellicciari, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) :3786-3794
[6]   PARP inhibitors bounce back [J].
Garber, Ken .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (10) :725-728
[7]   Building a Sulfonamide Library by Eco-Friendly Flow Synthesis [J].
Gioiello, Antimo ;
Rosatelli, Emiliano ;
Teofrasti, Michela ;
Filipponi, Paolo ;
Pellicciari, Roberto .
ACS COMBINATORIAL SCIENCE, 2013, 15 (05) :235-239
[8]   Toward a Continuous-Flow Synthesis of Boscalid® [J].
Glasnov, Toma N. ;
Kappe, C. Oliver .
ADVANCED SYNTHESIS & CATALYSIS, 2010, 352 (17) :3089-3097
[9]   TUMOR NECROSIS FACTOR-LIKE WEAK INDUCER OF APOPTOSIS AND FIBROBLAST GROWTH FACTOR-INDUCIBLE 14 MEDIATE CEREBRAL ISCHEMIA-INDUCED POLY(ADP-ribose) POLYMERASE-1 ACTIVATION AND NEURONAL DEATH [J].
Haile, W. B. ;
Echeverry, R. ;
Wu, F. ;
Guzman, J. ;
An, J. ;
Wu, J. ;
Yepes, M. .
NEUROSCIENCE, 2010, 171 (04) :1256-1264
[10]   Thieno[2,3-c]Isoquinolin-5-one, a Potent Poly(ADP-Ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High-Fat Diet-Fed Apolipoprotein E-Deficient Mice: Effects on Inflammatory Markers and Lipid Content [J].
Hans, Chetan P. ;
Zerfaoui, Mourad ;
Naura, Amarjit S. ;
Troxclair, Dana ;
Strong, Jack P. ;
Matrougui, Khalid ;
Boulares, A. Hamid .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (01) :150-158